Jin YX et al. |
Sphingosine kinase assay system with fluorescent detection in high performance liquid chromatography. |
2006 |
Arch. Pharm. Res. |
pmid:17146975
|
Chung FY et al. |
Signaling mechanisms of sphingosine 1-phosphate-induced ERK1/2 activation in cultured feline esophageal smooth muscle cells. |
2008 |
Arch. Pharm. Res. |
pmid:19023540
|
Lee CW et al. |
Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis. |
2010 |
Arch. Pharm. Res. |
pmid:21052934
|
Kim DS et al. |
Sphingosine-1-phosphate-induced ERK activation protects human melanocytes from UVB-induced apoptosis. |
2003 |
Arch. Pharm. Res. |
pmid:14560924
|
Pierucci F et al. |
Non-dioxin-like organic toxicant PCB153 modulates sphingolipid metabolism in liver progenitor cells: its role in Cx43-formed gap junction impairment. |
2017 |
Arch. Toxicol. |
pmid:27318803
|
Klingenberg R et al. |
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17761943
|
Hayashi H et al. |
FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19325137
|
Sanchez T et al. |
Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17431187
|
Ruiz M et al. |
High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. |
2017 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:27879252
|
Keul P et al. |
The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17158351
|
Walter DH et al. |
Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17158356
|
Auge N et al. |
Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. |
2002 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12482824
|
Medlin MD et al. |
Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:20702813
|
Bolick DT et al. |
Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15761190
|
Jang C et al. |
Angiopoietin-2 exocytosis is stimulated by sphingosine-1-phosphate in human blood and lymphatic endothelial cells. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19112163
|
Panetti TS et al. |
Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration. |
2000 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:10764666
|
Brinck JW et al. |
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection. |
2016 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:26966278
|
Daum G et al. |
Sphingosine 1-phosphate: a regulator of arterial lesions. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19592471
|
Tölle M et al. |
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. |
2008 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:18483405
|
Wamhoff BR et al. |
Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. |
2008 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:18535287
|
Grabski AD et al. |
Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19608972
|
Michaud MD et al. |
Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19423865
|
Smyth SS et al. |
Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis. |
2014 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:24482375
|
Kontush A et al. |
Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17569880
|
Rikitake Y et al. |
Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. |
2002 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11788469
|
Kim YM et al. |
G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate. |
2011 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:21212405
|
Yoshida T et al. |
Therapeutic angiogenesis by implantation of a capillary structure constituted of human adipose tissue microvascular endothelial cells. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:20431071
|
Sorci-Thomas MG and Thomas MJ |
High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:23077142
|
Frej C et al. |
A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex. |
2017 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:28385702
|
Tatematsu S et al. |
Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. |
2013 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:23723371
|
McGuire PG et al. |
Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier. |
2011 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:21940944
|
Denimal D et al. |
Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P Enrichment. |
2017 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:28360087
|
Gaengel K et al. |
Endothelial-mural cell signaling in vascular development and angiogenesis. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19164813
|
Murohara T |
Printing a tissue: a new engineering strategy for cardiovascular regeneration. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:20554948
|
Kimura T et al. |
High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12775579
|
Shimizu T et al. |
Sphingosine-1-phosphate receptor 3 promotes neointimal hyperplasia in mouse iliac-femoral arteries. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22308044
|
Kurano M et al. |
Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions. |
2017 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:28126827
|
Hao J et al. |
The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation. |
2014 |
Arthritis Res. Ther. |
pmid:25000985
|
Kamradt T and Frey O |
Arthritis: where are the T cells? |
2010 |
Arthritis Res. Ther. |
pmid:20537200
|
Stradner MH et al. |
Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes. |
2013 |
Arthritis Rheum. |
pmid:23666803
|
Kitano M et al. |
Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. |
2006 |
Arthritis Rheum. |
pmid:16508938
|
Callihan P et al. |
Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptor. |
2014 |
ASN Neuro |
pmid:25424429
|
Togame H et al. |
Development of a simple and robust assay to screen for inhibitors of sphingosine kinases. |
2007 |
Assay Drug Dev Technol |
pmid:17477830
|
Potì F et al. |
SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet. |
2015 |
Atherosclerosis |
pmid:25801013
|
Muehlich S et al. |
Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. |
2004 |
Atherosclerosis |
pmid:15262182
|
Tamama K et al. |
High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. |
2005 |
Atherosclerosis |
pmid:15585196
|
Bosteen MH et al. |
Effects of apolipoprotein M in uremic atherosclerosis. |
2017 |
Atherosclerosis |
pmid:28866363
|
Matsuo Y et al. |
Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. |
2007 |
Atherosclerosis |
pmid:17118370
|
Karuna R et al. |
Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. |
2011 |
Atherosclerosis |
pmid:21944699
|
Thors B et al. |
Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells. Differential role of protein kinase C. |
2003 |
Atherosclerosis |
pmid:12801607
|